Shana Lardi

Shana Lardi is a seasoned professional in the pharmaceutical sales industry, currently serving as a Neuroscience Sales Specialist at Intra-Cellular Therapies since November 2022. Previously, Lardi held the position of Neuroscience Account Manager at Lundbeck, where the focus was on promoting Rexulti and Trintellix to Psychiatrists and Mental Health Facilities. A long tenure at AstraZeneca included roles such as CV/Metabolic Specialty Sales Representative and consistently ranking as a top performer in CNS Specialty Sales. Lardi has launched significant pharmaceutical products, including Nexium and Symbicort, and has vast experience in promoting specialty drugs across various therapeutic areas. Lardi's early career involved roles in therapeutic specialty sales and account management, showcasing a diverse background that combines sales expertise with strong relationship management skills. Educational credentials include a Bachelor of Science in Hospitality Management from Florida International University and an Associate of Arts in Marketing from the University of Florida.